TALIGLUCERASE ALFA

576 reported adverse events

Drug classes: Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]

These side effects are most commonly reported by patients taking TALIGLUCERASE ALFA:

# Side effect Count
0 FATIGUE 71
1 ARTHRALGIA 47
2 HEADACHE 47
3 OFF LABEL USE 47
4 MALAISE 46
5 PAIN 46
6 PYREXIA 46
7 PAIN IN EXTREMITY 45
8 DYSPNOEA 40
9 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38
See all common reactions for TALIGLUCERASE ALFA

TALIGLUCERASE ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHITOTRIOSIDASE DECREASED 2 1.0000
1 CONGENITAL PARVOVIRUS B19 INFECTION 1 1.0000
2 ARBOVIRAL INFECTION 1 0.2000
3 SPLENIC FIBROSIS 2 0.1667
4 SLEEP APNOEA DEVICE IMPLANT 1 0.1250
5 CHITOTRIOSIDASE INCREASED 7 0.1148
6 GLUCOSYLSPHINGOSINE INCREASED 1 0.1111
7 FEAR OF CLOSED SPACES 1 0.0909
8 TARTRATE-RESISTANT ACID PHOSPHATASE INCREASED 1 0.0625
9 FALLOPIAN TUBE ENLARGEMENT 1 0.0556
See all enriched reactions for TALIGLUCERASE ALFA